Getting label-free cells does not have to be complicated. REAlease Technology relies on engineered antibody fragments that, when in a monomeric state, have low affinity for an epitope.
When multimerized in a biotinylated REAlease Complex, this complex binds to cell epitopes with high avidity. Together with a REAlease MicroBead, the target cell is magnetically labeled. During magnetic isolation, labeled target cells are retained within the column and thereby separated from non-labeled cells.
To get MicroBead-free target cells, the REAlease Release Reagent is applied to the column during the elution step. The eluted target cells are free from REAlease MicroBeads and can be subsequently used for a second round of magnetic isolation e.g. using regular MACS MicroBeads.
Label-free target cells can be obtained by addition of the REAlease Release Reagent. This leads to monomerization of the antibody fragments and dissociation of the complex from the cell surface. The result: cells that are free of any labels. As their epitopes are completely available for re-labeling, the cells are suited for any downstream application.